GlassScriptPhysician profile
Paula Baker
NPI 1902109879
$817.40
in general payments reported to CMS, 2019-2025
17 companies · $15.73 in 2025
The $15.73 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $346 · 2025: $15.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $139.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.50 | 2022 | |
| Amgen INC. | $115.20 | 2022 | |
| Genentech USA, INC. | $63.40 | 2021 | |
| Csl Behring | $61.56 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $51.04 | 2021-2022 | |
| Glaxosmithkline, LLC. | $38.48 | 2021 | |
| Kaleo, INC. | $32.19 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.61 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $26.76 | 2021 | |
| Baxter Healthcare | $26.15 | 2022 | |
| Horizon Therapeutics Plc | $25.00 | 2021 | |
| Genzyme Corporation | $20.95 | 2022 | |
| Adma Biomanufacturing LLC | $18.84 | 2021 | |
| Grifols USA, LLC | $17.02 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.85 | 2022 | |
| Medline Industries LP | $15.73 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.